Hammarskjöld Foundation, D., “Who We Are,” available at <http://www.daghammarskjold.se/who-we-are> (last visited June 10, 2015).+(last+visited+June+10,+2015).>Google Scholar

Global Strategy Lab, “Mission,” available at <http://www.globalstrategy.ninja/about> (last visited June 10, 2015).+(last+visited+June+10,+2015).>Google Scholar

American Society of Law, Medicine & Ethics, Journal of Law, Medicine & Ethics, “Back Issues and Articles,” available at <http://www.aslme.org/Back_Issues_And_Articles?journal=JLME> (last visited June 10, 2015).+(last+visited+June+10,+2015).>Google Scholar

Norwegian Institute of Public Health, “Better Health for All,” available at <http://www.fhi.no/eway/?pid=240> (last visited June 10, 2015).+(last+visited+June+10,+2015).>Google Scholar

ReAct – Action on Antibiotic Resistance, “Who We Are,” available at <http://www.reactgroup.org/who-we-are.html> (last visited June 10, 2015).+(last+visited+June+10,+2015).>Google Scholar

Barlam, T. F. Gupta, K., “Antibiotic Resistance Spreads Internationally Across Borders,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.CrossRefGoogle Scholar

Hoffman, S. J. Outterson, K. Røttingen, J.-A. Cars, O. Clift, C. Rizvi, Z. et al., “An International Legal Framework to Address Antimicrobial Resistance,” Bulletin of the World Health Organization 93, no. 2 (2015): 66.Google Scholar

Daulaire, N. Bang, A. Tomson, G. Kalyango, J. N. Cars, O., “Universal Access to Effective Antibiotics is Essential for Tackling Antibiotic Resistance,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.CrossRefGoogle Scholar

Review on Antimicrobial Resistance, “Tackling Drug-Resistant Infections Globally,” available at <http://amr-review.org/home> (last visited June 11, 2015).+(last+visited+June+11,+2015).>Google Scholar

Clift, C. Gopinathan, U. Morel, C. Outterson, K. Røttingen, J.-A. So, A. D., Towards a New Global Business Model for Antibiotics: Report from the Chatham House Working Group on New Antibiotic Business Models (Chatham House, 2015).Google Scholar

World Health Organization: Draft Global Action Plan on Antimicrobial Resistance, World Health Organization, available at <http://www.who.int/drugresistance/AMR_DRAFT_GAP_1_Oct_2014_for_MS_consultation.pdf> (last visited June 11, 2015).+(last+visited+June+11,+2015).>Google Scholar

Outterson, K. Powers, J. H. Daniels, G. W. McClellan, M. B., “Repairing the Broken Market for Antibiotic Innovation,” Health Affairs 34, no. 2 (2015): 277–285.CrossRefGoogle Scholar

Balasegaram, M. Clift, C. Røttingen, J.-A., “The Global Innovation Model for Antibiotics Needs Reinvention,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.CrossRefGoogle Scholar

Podolsky, S. H. Bud, R. Gradmann, C. Hobaek, B. Kirchhelle, C. Mitvedt, T. Santesmases, M. J. Thoms, U. Berild, D. Kveim Lie, A., “History Teaches Us That Confronting Antibiotic Resistance Requires Stronger Global Collective Action,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.CrossRefGoogle Scholar

Hollis, A. Maybarduk, P., “Antibiotic Resistance Is a Tragedy of the Commons That Necessitates Global Cooperation,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.CrossRefGoogle Scholar

So, A. D. Shah, T. A. Roach, S. Chee, Y. L. Nachman, K. E., “An Integrated Systems Approach is Needed to Ensure the Sustainability of Antibiotic Effectiveness for Both Humans and Animals,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.CrossRefGoogle Scholar

Andresen, S. Hoffman, S. J., “Much Can Be Learned about Addressing Antibiotic Resistance from Multilateral Environmental Agreements,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.Google Scholar

Hoffman, S. J. Ottersen, T., “Addressing Antibiotic Resistance Requires Robust International Accountability Mechanisms,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.CrossRefGoogle Scholar

Hoffman, S. J. Røttingen, J.-A. Frenk, J., “International Law Has a Role to Play in Addressing Antibiotic Resistance,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.Google Scholar

Hoffman, S. J. Røttingen, J.-A., “A Framework Convention on Obesity Control?” The Lancet 378, no. 9809 (2011): 2068; Hoffman, S. J. Røttingen, J.-A., “Be Sparing With International Laws,” Nature 483, no. 7389 (2012): 275; Hoffman, S. J. Røttingen, J.-A., “Dark Sides of the Proposed Framework Convention on Global Health's Many Virtues: A Systematic Review and Critical Analysis,” Health and Human Rights 15, no. 1 (2013): E117–E134; Hoffman, S. J. Røttingen, J.-A., “Assessing the Expected Impact of Global Health Treaties: Evidence from 90 Quantitative Evaluations,” American Journal of Public Health 105, no. 1 (2015): 26–40; Hoffman, S. J. Røttingen, J.-A. Frenk, J., “Assessing Proposals for New Global Health Treaties: An Analytic Framework,” American Journal of Public Health (2015): e1–e8.CrossRefGoogle Scholar

See Hoffman, Røttingen Frenk, , supra note 20.Google Scholar

Behdinan, A. Hoffman, S. J. Pearcey, M., “Some Global Policies for Antibiotic Resistance Depend on Legally Binding and Enforceable Commitments,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Available via aslme.org.CrossRefGoogle Scholar

Rizvi, Z. Hoffman, S. J., “Effective Global Action on Antibiotic Resistance Requires Careful Consideration of Convening Forums,” Journal of Law, Medicine & Ethics 43, no. 2, Supp. (2015): Online only.CrossRefGoogle Scholar

Hoffman, S. J., “A Science of Global Strategy,” in Frenk, J. Hoffman, S. J., eds., “To Save Humanity”: What Matters Most for a Healthy Future (New York: Oxford University Press, 2015): At 173–175.Google Scholar

ReAct – Action on Antibiotic Resistance, “Royal Recognition and New Antibiotics Center Confirmed,” available at <http://www.reactgroup.org/news/496/18.html> (last visited June 10, 2015).+(last+visited+June+10,+2015).>Google Scholar